Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma https://t.co/R3PiI4QRmL "identified E2F as a potential target of metformin that has not been previously identified"
The new RCHOP
RT @Lymphoma_Papers: Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphom…
RT @Lymphoma_Papers: Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphom…